Nexalin Technology NXL
NASDAQ NXL
$4.21 -0.14 (-3.22%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Non-Current Debt (2021)

Updated

Nexalin Technology (NXL) recorded Non-Current Debt of $22,916 in Q4 2021.

Analysis

Nexalin Technology (NXL) Non-Current Debt (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 39.18 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 29.60 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 25.15 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 25.62 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 14.19 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 10.92 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 598.70 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 13.51 Bn
10 Nexalin Technology 3.09 Mn -8.70 Mn 8,897.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 22,916.00
API Access

Nexalin Technology Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NXL&period=max&api_key=YOUR_API_KEY